• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-(对氯苯硫基)丁醇(W-2719)在大鼠和犬体内的代谢及药代动力学

Metabolism and pharmacokinetics of 4-(p-chlorophenylthio)butanol (W-2719) in the rat and dog.

作者信息

Kucharczyk N, Edelson J, Sofia R D, Ludwig B J, Shahinian S, Schuster E, Ballard F H, Yang J, Myers G

出版信息

Arzneimittelforschung. 1979;29(10):1550-6.

PMID:583221
Abstract

4-(p-Chlorophenylthio)butanol (W-2719) administered orally to rats and dogs is rapidly absorbed, metabolized and excreted. The only major biotransformation product found in blood was p-chlorophenylthioacetic acid (W-2683). No W-2719 or the intermediary p-chlorophenylthiobutyric acid (W-2718) could be found in plasma after oral administration of the drug. When W-2719 was given i.v. to dogs, both W-2719 and W-2718 appeared in plasma but each had a very short half-life of about 10 min. After an oral dose of W-2719 to dogs the plasma content of W-2683 peaked at 4-6 h, amounting to approximately 20% of the dose. More than 91% of the dose was excreted with 48 h, 83% in urine and 9% in feces. The predominant excretion product in urine was p-chlorothiophenol, most of which was excreted in a conjugated form. The other major urinary metabolite was W-2683, while smaller amounts of W-2718 and unchanged drug were also found. No significant effect of prolonged dosing of 14C-W-2719 to dogs was observed on plasma 14C levels, peak time, 14C half-life or excretion and composition patterns.

摘要

4-(对氯苯硫基)丁醇(W-2719)经口服给予大鼠和狗后,会迅速被吸收、代谢和排泄。血液中发现的唯一主要生物转化产物是对氯苯硫基乙酸(W-2683)。口服该药物后,血浆中未发现W-2719或中间产物对氯苯硫基丁酸(W-2718)。当给狗静脉注射W-2719时,W-2719和W-2718均出现在血浆中,但它们的半衰期都很短,约为10分钟。给狗口服一剂W-2719后,W-2683的血浆含量在4至6小时达到峰值,约占剂量的20%。超过91%的剂量在48小时内排出,83%通过尿液排出,9%通过粪便排出。尿液中主要的排泄产物是对氯苯硫酚,其中大部分以结合形式排出。另一种主要的尿液代谢产物是W-2683,同时也发现了少量的W-2718和未变化的药物。对狗长期给予14C-W-2719,未观察到对血浆14C水平、峰值时间、14C半衰期或排泄及组成模式有显著影响。

相似文献

1
Metabolism and pharmacokinetics of 4-(p-chlorophenylthio)butanol (W-2719) in the rat and dog.4-(对氯苯硫基)丁醇(W-2719)在大鼠和犬体内的代谢及药代动力学
Arzneimittelforschung. 1979;29(10):1550-6.
2
The pharmacodynamics of 4-(p-chlorophenylthio)butanol (W-2719) in humans.4-(对氯苯硫基)丁醇(W-2719)在人体中的药效学。
Arzneimittelforschung. 1979;29(11):1756-8.
3
[Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].[大鼠和犬中镇痛药氟吡汀的药代动力学及生物转化]
Arzneimittelforschung. 1985;35(1):60-7.
4
Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.酮色林在大鼠、兔和犬体内的药代动力学及组织分布
Arzneimittelforschung. 1988 Jun;38(6):775-84.
5
Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.N,N-二乙基间甲苯酰胺在大鼠体内的吸收、分布、代谢及排泄
Drug Metab Dispos. 1996 Feb;24(2):156-63.
6
Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.新型降胆固醇化合物S-8921在大鼠和犬体内的处置与代谢
Arzneimittelforschung. 1998 Oct;48(10):995-1006.
7
Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.尼莫地平的药代动力学。I. 通讯:大鼠、狗和猴单次给予[14C]尼莫地平后的吸收、血浆浓度及排泄
Arzneimittelforschung. 1985;35(12):1781-6.
8
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
9
Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.普卢利沙星的药代动力学。首次通信:单次给药后在大鼠、狗和猴子体内的吸收、分布及排泄情况
Arzneimittelforschung. 1997 Mar;47(3):276-84.
10
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.新型类视黄醇4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸的代谢与处置研究。第四次通讯:在各种动物和人类中的吸收、代谢、排泄及血浆蛋白结合情况
Arzneimittelforschung. 1997 Mar;47(3):259-69.